| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,301 |
6,901 |
$1.17M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,948 |
3,758 |
$774K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
722 |
688 |
$386K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,698 |
1,618 |
$247K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,437 |
1,407 |
$145K |
| 70450 |
Computed tomography, head or brain; without contrast material |
593 |
573 |
$144K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
120 |
116 |
$49K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
364 |
352 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,733 |
1,571 |
$16K |
| 87070 |
|
230 |
227 |
$324.05 |
| 71046 |
Radiologic examination, chest; 2 views |
733 |
718 |
$315.33 |
| 84484 |
|
1,064 |
956 |
$288.80 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,239 |
1,219 |
$244.72 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,724 |
1,623 |
$242.95 |
| 71045 |
Radiologic examination, chest; single view |
1,196 |
1,146 |
$232.50 |
| 87807 |
|
139 |
138 |
$82.36 |
| 80053 |
Comprehensive metabolic panel |
4,863 |
4,448 |
$73.46 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
806 |
774 |
$52.59 |
| 81025 |
|
1,834 |
1,752 |
$16.21 |
| 81003 |
|
3,064 |
2,869 |
$4.61 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,435 |
2,288 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,689 |
1,545 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,499 |
1,414 |
$0.00 |
| 87088 |
|
543 |
522 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
832 |
782 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,161 |
4,676 |
$0.00 |
| 87430 |
|
536 |
519 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
299 |
283 |
$0.00 |
| 83605 |
|
182 |
167 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,057 |
1,040 |
$0.00 |
| 96376 |
|
140 |
118 |
$0.00 |
| 83735 |
|
14 |
12 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
26 |
25 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
400 |
320 |
$0.00 |
| 36416 |
|
14 |
14 |
$0.00 |
| 82150 |
|
15 |
14 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
12 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
41 |
39 |
$0.00 |
| 80320 |
|
13 |
12 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
26 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
14 |
13 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,550 |
1,385 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
307 |
294 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
35 |
33 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,010 |
963 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
118 |
116 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
274 |
241 |
$0.00 |
| 82948 |
|
91 |
56 |
$0.00 |
| 73630 |
|
44 |
43 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 94664 |
|
38 |
36 |
$0.00 |
| 73610 |
|
13 |
13 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$0.00 |